Saypha Volume side effects are among the top concerns for aesthetic doctors using dermal fillers in mid- and deep-volume restoration. Manufactured by Croma-Pharma GmbH, Saypha Volume (formerly known as Princess Volume) is a hyaluronic acid (HA) filler designed for restoring facial volume and treating deep wrinkles. This guide outlines key safety considerations, potential risks, injection techniques, and clinical data to assist medical professionals in delivering optimal patient outcomes.

---

What is Saypha Volume (23 mg/ml)?

Saypha Volume is a monophasic, cross-linked HA dermal filler indicated for:

• Deep facial wrinkles (e.g., nasolabial folds)
• Facial volume loss (cheeks, temples, chin)
• Mid-face augmentation

Product specifications:

• HA concentration: 23 mg/ml
• Cross-linking agent: BDDE (minimal residuals)
• Format: 1 x 1 ml prefilled syringe
• Lidocaine: Optional version available

Manufacturer: Croma-Pharma GmbH (Austria)
Certification: CE Class III medical device

Official site: https://croma.at/en/products/saypha-volume

---

Common and Rare Side Effects of Saypha Volume

Like all HA fillers, Saypha Volume is generally well tolerated but may present local or rare systemic adverse events.

Table 1: Saypha Volume Side Effects

Side Effect	Frequency	Notes
Redness, swelling	Very common	Resolves within 2–3 days
Bruising	Common	Related to injection depth or needle size
Tenderness, itching	Common	Mild and self-limiting
Lumps or nodules	Occasional	May result from overcorrection or poor technique
Hypersensitivity reaction	Rare	Monitor for redness, warmth, systemic symptoms
Vascular occlusion	Very rare	Emergency; immediate protocol required

Sources: Croma Safety Data, PubMed Review on HA Fillers

---

Injection Techniques and Anatomical Guidelines

Saypha Volume is designed for injection into the deep dermis, subcutaneous tissue, or supraperiosteal plane, depending on the area treated.

Table 2: Recommended Injection Techniques

Treatment Area	Depth	Technique	Notes
Cheeks	Supraperiosteal	Bolus or fanning	Use cannula or needle 25–27G
Nasolabial folds	Mid to deep dermis	Linear threading or fanning	Avoid overfilling
Chin	Supraperiosteal	Bolus injections	Assess facial symmetry
Temples	Deep subcutaneous	Retrograde linear threading	Low volume, high precision

---

Safety Protocols and Complication Management

Prevention strategies:

• Use aspiration before injection in high-risk zones
• Employ slow injection and minimal pressure
• Avoid vascular danger zones without anatomical training

Table 3: Adverse Event Management

Complication	Prevention	Management
Vascular occlusion	Slow injection, aspiration	Hyaluronidase, warm compress, referral
Lumps/nodules	Proper depth, avoid overfilling	Massage, hyaluronidase if persistent
Inflammation/allergy	Screen patient history	Antihistamines, corticosteroids if needed

---

Saypha Volume vs Other HA Fillers

Attribute	Saypha Volume	Typical HA Filler
HA concentration	23 mg/ml	20–25 mg/ml
Cross-linking agent	BDDE (low residuals)	Varies
Particle structure	Monophasic, smooth	Varies
Longevity	6–12 months	6–12 months
Origin	Biofermentation	Common across HA fillers

---

Patient Selection and Aftercare

Ideal candidates:

• Adults aged 30–65 with mid-face volume loss
• No active skin infections or autoimmune conditions
• Informed, realistic expectations

Aftercare instructions:

• Avoid intense heat (sauna, sun) for 48 hours
• No alcohol or exercise 24 hours post-treatment
• Gentle cleansing; no pressure on treated area
• Return if pain, discoloration, or swelling persists

---

Summary: Clinical Profile of Saypha Volume

Attribute	Specification
Product name	Saypha Volume 23 mg/ml
Indications	Volume loss, facial contouring
Duration of effect	Up to 12 months
Reversible	Yes, with hyaluronidase
CE certification	Yes (Class III Medical Device)
Manufacturer	Croma-Pharma GmbH (Austria)
Suitable injection plane	Deep dermis, subcutaneous, supraperiosteal

---

References

• Croma-Pharma Official Product Page
• PubMed: HA Filler Complication Review
• ISAPS Guidelines on Dermal Fillers

---